Miruvor
Sign up
Long COVID Outcome unclear

Long COVID, unclear effect from microdosing tirzepatide, mild headache after first shot

Condition
Long COVID
At worst
Not stated
Ill for
Not stated
Last post
Jan 2026
In their words
Read from 1 of their posts and comments; links to the one this page draws on

Request to remove this story

Summary

Spruce 38989 wrote in January 2026 about microdosing tirzepatide, starting at 0.7 mg and dropping to 0.5 mg because weight was falling too quickly and weight loss was not the aim. The only effect noted was a mild headache after the first shot. Nothing was said about their illness, its onset, how long they had been ill or how limited they were.

Ask Miruvor AI

Asking aboutSpruce 38989’s story

What they tried

Their words about each treatment
  • Tirzepatide · Not saidAt my micro dose levels I only experienced a mild headache after the first shot and nothing else. In context ↗

Adverse events

Symptoms mentioned

Their words about their symptoms
  • Headaches & migraineAt my micro dose levels I only experienced a mild headache after the first shot and nothing else. In context ↗

Ask Miruvor AI

Asking aboutSpruce 38989’s story

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime